The Impact of Micropapillary Component Ratio on the Prognosis of Patients With Invasive Micropapillary Breast Carcinoma

REFERENCES

• Thapa B, Singh Y, Sayami P, Shrestha UK, Sapkota R, Sayami G. Breast cancer in young women from a low risk population in Nepal. Asian Pac J Cancer Prev. 2013;14(9):5095–99. doi:10.7314/APJCP.2013.14.9.5095. PMID:24175782.
   PubMedGoogle Scholar
• Zob D, Vasilescu M, Gruia MI, Anghel R. Breast cancer. Screening criteria. Chirurgia. 2013;108:557–62. PMID:23958102.
   PubMed Web of Science ®Google Scholar
• Ellis IO, Cornelisse CJ, Schnitt SJ, et al. Invasive breast carcinomas. In: Tavassoli FA, Devilee P, editors. WHO classification of tumours pathology and genetics of tumours of the breast and female genital organs. Lyon: IARC Press; 2003. p. 13–9.
   Google Scholar
• Weigelt B, Reis-Filho JS. Histological and molecular types of breast cancer: is there a unifying taxonomy? Nat Rev Clin Oncol. 2009;6(12):718–30. doi:10.1038/nrclinonc.2009.166. PMID:19942925.
   PubMed Web of Science ®Google Scholar
• Fisher ER, Palekar AS, Redmond C, Barton B, Fisher B. Pathologic findings from the national surgical adjuvant breast project (protocol no. 4). vi. invasive papillary cancer. Am J Clin Pathol. 1980;73:313–22. doi:10.1093/ajcp/73.3.313. PMID:7361710.
   PubMed Web of Science ®Google Scholar
• Petersen JL. Breast carcinomas with an unexpected inside-out growth pattern: rotation of polarization associated with angioinvasion. Pathol Res Pract. 1993;189:A780.
   Google Scholar
• Lotan TL, Ye H, Melamed J, Wu XR, Shih leM, Epstein JI. Immunohistochemical panel to identify the primary site of invasive micropapillary carcinoma. Am J Surg Pathol. 2009;33:1037–41. doi:10.1097/PAS.0b013e3181962dcd. PMID:19238079.
   PubMed Web of Science ®Google Scholar
• Lakhani SR. Who classification of tumours of the breast. France, FL: IARC; 2012. p. 65.
   Google Scholar
• Chen AC, Paulino AC, Schwartz MR, et al. Population-based comparison of prognostic factors in invasive micropapillary and invasive ductal carcinoma of the breast. Br J Cancer. 2014;111:619–22. doi:10.1038/bjc.2014.301. PMID:24921921.
   PubMed Web of Science ®Google Scholar
• Acs G, Esposito NN, Rakosy Z, Larongo C, Zhang PJ. Invasive ductal carcinomas of the breast showing partial reversed cell polarity are associated with lymphatic tumor spread and may represent part of a spectrum of invasive micropapillary carcinoma. Am J Surg Pathol. 2010;34:1637–46. PMID:20975342.
   PubMed Web of Science ®Google Scholar
• Nassar H, Wallis T, Andea A, Dey J, Adsay V, Visscher D. Clinicopathologic analysis of invasive micropapillary differentiation in breast carcinoma. Mod Pathol. 2001;14:836–41. doi:10.1038/modpathol.3880399. PMID:11557778.
   PubMedGoogle Scholar
• Pettinato G, Manivel CJ, Panico L, Sparano L, Petrella G. Invasive micropapillary carcinoma of the breast: clinicopathologic study of 62 cases of a poorly recognized variant with highly aggressive behavior. Am J Clin Pathol. 2004;121:857–66. doi:10.1309/XTJ7VHB49UD78X60.
   PubMed Web of Science ®Google Scholar
• Chen L, Fan Y, Lang RG, et al. Breast carcinoma with micropapillary features: clinicopathologic study and long-term follow-up of 100 cases. Int J Surg Pathol. 2008;16:155–63. doi:10.1177/1066896907307047. PMID:18417672.
   PubMed Web of Science ®Google Scholar
• De la Cruz C, Moriya T, Endoh M, et al. Invasive micropapillary carcinoma of the breast: Clinicopathological and immunohistochemical study. Pathol Int. 2004;54:90–6. doi:10.1111/j.1440-1827.2004.01590.x. PMID:14720138.
   PubMed Web of Science ®Google Scholar
• Kuroda H, Sakamoto G, Ohnisi K, Itoyama S. Clinical and pathologic features of invasive micropapillary carcinoma. Breast Cancer 2004;11(2):169–74. doi:10.1007/BF02968297. PMID:15550863.
   PubMedGoogle Scholar
• Shi WB, Yang LJ, Hu X, Zhou J, Zhang Q, Shao Z. Clinico-pathological features and prognosis of invasive micropapillary carcinoma compared to invasive ductal carcinoma: a population-based study from China. PLoS One. 2014;9:e101390. doi:10.1371/journal.pone.0101390. PMID:24977705.
   PubMed Web of Science ®Google Scholar
• Yu JI, Choi DH, Park W, et al. Differences in prognostic factors and patterns of failure between invasive micropapillary carcinoma and invasive ductal carcinoma of the breast: matched case-control study. Breast. 2010;19:231–37. doi:10.1016/j.breast.2010.01.020. PMID:20304650.
   PubMed Web of Science ®Google Scholar
• Böcker W. WHO classification of breast tumors and tumors of the female genital organs: pathology and genetics. Verh Dtsch Ges Pathol. 2002;86:116–19. PMID:12647359.
   PubMedGoogle Scholar
• Edge SB, Byrd DR, Compton CC, Fritz AG, Greene F, Trotti A. AJCC cancer staging manual. 7th ed. New York (NY): Springer; 2009. 589 p.
   Google Scholar
• Guo X, Chen L, Lang R, Fan Y, Zhang X, Fu L. Invasive micropapillary carcinoma of the breast: association of pathologic features with lymph node metastasis. Am J Clin Pathol. 2006;126:740–46. doi:10.1309/AXYY4AJTMNW6FRMW.
   PubMed Web of Science ®Google Scholar
• Hammond ME, Hayes DF, Dowsett M, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol. 2010;28:2784–95. doi:10.1200/JCO.2009.25.6529. PMID:20404251.
   PubMed Web of Science ®Google Scholar
• Wolff AC, Hammond ME, Schwartz JN, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol. 2007;25:118–45. doi:10.1200/JCO.2006.09.2775. PMID:17159189.
   PubMed Web of Science ®Google Scholar
• Goldhirsch A, Wood WC, Coates AS, et al. Strategies for subtypes – dealing with the diversity of breast cancer: highlights of the St. gallen international expert consensus on the primary therapy of early breast cancer 2011. Ann Oncol. 2011;22:1736–47. doi:10.1093/annonc/mdr304. PMID:21709140.
   PubMed Web of Science ®Google Scholar
• Swanick CW, Smith BD. Indications for adjuvant radiation therapy in breast cancer: a review of the evidence and recommendations for clinical practice. Chin Clin Oncol. 2016;5:38. doi:10.21037/cco.2016.03.15. PMID:27164850.
   PubMed Web of Science ®Google Scholar
• Ellis IO, Galea M, Broughton N, Locker A, Blamey RW, Elston CW. Pathological prognostic factors in breast cancer, II: histological type: relationship with survival in a large study with long-term follow-up. Histopathology. 1992;20: 479–89. doi:10.1111/j.1365-2559.1992.tb01032.x. PMID:160714
   PubMed Web of Science ®Google Scholar
• Ide Y, Horii R, Osako T, et al. Clinicopathological significance of invasive micropapillary carcinoma component in invasive breast carcinoma. Pathol Int. 2011;61:731–36. doi:10.1111/j.1440-1827.2011.02735.x.
   PubMed Web of Science ®Google Scholar
• Walsh MM, Bleiweiss IJ. Invasive micropapillary carcinoma of the breast: eighty cases of an under-recognized entity. Hum Pathol. 2001;32:583–89. doi:10.1053/hupa.2001.24988. PMID:11431712.
   PubMed Web of Science ®Google Scholar
• Nenutil R. A revolution postponed indefinitely. WHO classification of tumors of the breast 2012: the main changes compared to the 3rd edition, 2003. Cesk Patol. 2015;51:23–5. PMID:25671358.
   PubMedGoogle Scholar
• Wu Y, Zhang N, Yang Q. The prognosis of invasive mic-ropapillary carcinoma compared with invasive ductal carcinoma in the breast: a meta-analysis. BMC Cancer. 2017;17:839–847. doi:10.1186/s12885-017-3855-7. PMID:29228910.
   PubMed Web of Science ®Google Scholar
• Li G, Yang S, Yao J, et al. Invasive micropapillary carcinoma of the breast had poor clinical characteristics but showed no difference in prognosis compared with invasive ductal carcinoma. World J Surg Oncol. 2016;14:207–13. doi:10.1186/s12957-016-0960-z. PMID:27492008.
   PubMed Web of Science ®Google Scholar
• Yamaguchi R, Tanaka M, Kondo K, et al. Characteristic morphology of invasive micropapillary carcinoma of the breast: an immunohistochemical analysis. Jpn J Clin Oncol. 2010;40:781–87. doi:10.1093/jjco/hyq056. PMID:20444748.
   PubMed Web of Science ®Google Scholar
• Paterakos M, Watkin WG, Edgerton SM, Moore DH 2nd, Thor AD. Invasive micropapillary carcinoma of the breast: a prognostic study. Hum Pathol. 1999;30:1459–63. doi:10.1016/S0046-8177(99)90168-5. PMID:10667424.
   PubMed Web of Science ®Google Scholar
• Abi-Raad R, Boutrus R, Wang R, et al. Patterns and risk factors of locoregional recurrence in T1-T2 node negative breast cancer patients treated with mastectomy: implications for postmastectomy radiotherapy. Int J Radiat Oncol Biol Phys. 2011;81:151–57. doi:10.1016/j.ijrobp.2011.01.015.
   Web of Science ®Google Scholar
• Middleton LP, Tressera F, Sobel ME, et al. Infiltrating micropapillary carcinoma of the breast. Mod Pathol. 1999;12:499–504. PMID:10349988.
   PubMed Web of Science ®Google Scholar
• Zekioglu O, Erhan Y, Ciris M, Bayramoğlu H, Özdemir N. Invasive micropapillary carcinoma of the breast: high incidence of lymph node metastasis with extension and its immunohistochemical profile compared with invasive ductal carcinoma. Histopathology. 2004;44:18–23. doi:10.1111/j.1365-2559.2004.01757.x. PMID:14717664.
   PubMed Web of Science ®Google Scholar
• Luna-Moré S, Casquero S, Pérez-Mellado A, Rius F, Weill B, Gornemann I. Importance of estrogen receptors for the behavior of invasive micropapillary carcinoma of the breast. Review of 68 cases with follow-up of 54. Pathol Res Pract. 2000;196:35–9. doi:10.1016/S0344-0338(00)80019-9. PMID:10674270.
   PubMed Web of Science ®Google Scholar
• Gutierrez C, Schiff R. HER2 biology, detection, and clinical implications. Arch Pathol Lab Med. 2011;135:55–62. PMID:21204711.
   PubMed Web of Science ®Google Scholar
• Anderson WF, Rosenberg PS, Prat A, Perou CM, Shermann ME. How many etiological subtypes of breast cancer: two, three, four, or more? J Natl Cancer Inst. 2014;106:dju165. doi:10.1093/jnci/dju165. PMID:25118203.
   PubMedGoogle Scholar
• Kim DS, Cho N, Ko ES, et al. Imaging and the clinical-pathologic features of invasive micropapillary carcinoma of the breast. J Korean Radio Soc. 2007;56:497–503. doi:10.3348/jkrs.2007.56.5.497.
   Google Scholar
• Tresserra F, Grases PJ, Fábregas R, Fernandez-Cid A, Dexeus S. Invasive micropapillary carcinoma. Distinct features of a poorly recognized variant of breast carcinoma. Eur J Gynaecol Oncol. 1999;20:205–8. PMID:10410887.
   PubMed Web of Science ®Google Scholar
• Ueda S, Tsuda H, Asakawa H, et al. Clinicopathological and prognostic relevance of uptake level using 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in primary breast cancer. Jpn J Clin Oncol. 2008;38:250–58. doi:10.1093/jjco/hyn019. PMID:18407934.
   PubMed Web of Science ®Google Scholar
• Umeda T, Ishida M, Murata S, et al. Immunohistochemical analyses of CD44 variant isoforms in invasive micropapillary carcinoma of the breast: comparison with a concurrent conventional invasive carcinoma of no special type component. Breast Cancer. 2016;23:869–75. doi:10.1007/s12282-015-0653-4. PMID:26494575.
   PubMed Web of Science ®Google Scholar
• Kuroda H, Sakamoto G, Ohnisi K, Itoyama S. Clinical and pathologic features of invasive micropapillary carcinoma. Breast Cancer. 2004;11:169–74. doi:10.1007/BF02968297. PMID:15550863.
   PubMedGoogle Scholar
• Vera-Badillo FE, Napoleone M, Ocana A, et al. Effect of multifocality and multicentricity on outcome in early stage breast cancer: a systematic review and meta-analysis. Breast Cancer Res Treat. 2014;146:235–44. doi:10.1007/s10549-014-3018-3. PMID:24928527.
   PubMed Web of Science ®Google Scholar
• Tang S, Yang J, Du ZG, et al. Clinicopathologic study of invasive micropapillary carcinoma of the breast. Oncotarget. 2017;8:42455–65. PMID:28418916
   PubMedGoogle Scholar